Positions & consultation responses
Response to European Commission Call for Evidence on EU Regulatory Framework for Financial Services
Positions & consultation responses
31 Jan 2016
EVCA-PAE Response to Green Paper on Capital Markets Union
Positions & consultation responses
13 May 2015
EC Green Paper on Capital Markets Union
Positions & consultation responses
18 Feb 2015
Response to the European Commission Consultation on the Rescue and Restructuring Guidelines
Positions & consultation responses
13 Nov 2025
Position paper on the next EU Budget
Positions & consultation responses
30 Oct 2025
Response to the European Commission Consultation on the 28th regime
Positions & consultation responses
29 Sep 2025
Response to the European Commission Consultation on the General Block Exemption Regulation (GBER)
Positions & consultation responses
29 Sep 2025
InvestEU Interim Evaluation Consultation Response
Positions & consultation responses
10 May 2023
Letter on state aid issues related to SME Definition
Positions & consultation responses
28 Apr 2020
MEMBER ONLY
EVCA Corporate Venturing European Activity Report 2002
Positions & consultation responses
01 Oct 2003
Position on the Scope of the Leaked 28th Regime Corporate Legal Framework (EU Inc.)
Positions & consultation responses
17 Mar 2026
Position Paper on Biotech & Healthcare
Positions & consultation responses
03 Nov 2025
Response to the European Commission Consultation on the European Innovation Act (EIA)
Positions & consultation responses
29 Sep 2025
Response to the European Commission Call for Evidence on the European Biotech Act
Positions & consultation responses
06 Jun 2025
Position paper on EU response to the US Inflation Reduction Act
Positions & consultation responses
16 Mar 2023
Response to the Commission’s targeted survey on simplifying the General Block Exemption Regulation (GBER)
Positions & consultation responses
02 Jul 2026
Position on the draft 2027-2034 General Block Exemption Regulation (GBER)
Positions & consultation responses
17 Apr 2026
Position on the European Biotech Act I
Positions & consultation responses
29 Apr 2026